share_log

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

SEC announcement ·  Jun 19 04:21
Summary by Futu AI
Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.